GlassScriptPhysician profile
David M Hyams
NPI 1992755391
$6,180.16
in general payments reported to CMS, 2019-2025
13 companies · $278 in 2025
The $278 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,454 · 2022: $47.39 · 2023: $387 · 2024: $13.58 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $678.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $5,067.79 | 2019 | |
| Endomagnetics LTD | $173.80 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $143.68 | 2023 | Opdivo |
| Galvanize Therapeutics, INC | $135.52 | 2025 | Aliya System |
| Abbott Laboratories | $133.84 | 2019 | |
| Amgen INC. | $121.87 | 2023 | Evenity |
| Boston Scientific Corporation | $93.66 | 2023 | Ams 700 |
| Vertex Pharmaceuticals Incorporated | $86.02 | 2025 | |
| Conformis, INC. | $78.95 | 2019 | |
| Exact Sciences Corporation | $56.06 | 2025 | |
| Sirius Medical Systems | $41.58 | 2023-2024 | Pintuition |
| Integra Lifesciences Corporation | $28.11 | 2022 | |
| Kci USA, INC. | $19.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hyams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.